Cargando…

Aurora kinases: novel therapy targets in cancers

Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Anqun, Gao, Keyu, Chu, Laili, Zhang, Rui, Yang, Jing, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410356/
https://www.ncbi.nlm.nih.gov/pubmed/28147341
http://dx.doi.org/10.18632/oncotarget.14893
_version_ 1783232665037570048
author Tang, Anqun
Gao, Keyu
Chu, Laili
Zhang, Rui
Yang, Jing
Zheng, Junnian
author_facet Tang, Anqun
Gao, Keyu
Chu, Laili
Zhang, Rui
Yang, Jing
Zheng, Junnian
author_sort Tang, Anqun
collection PubMed
description Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicated in regulating meiosis. The deletion of Aurora kinases could lead to failure of cell division and impair the embryonic development. Overexpression or gene amplification of Aurora kinases has been clarified in a number of cancers. And a growing number of studies have demonstrated that inhibition of Aurora kinases could potentiate the effect of chemotherapies. For the past decades, a series of Aurora kinases inhibitors (AKIs) developed effectively repress the progression and growth of many cancers both in vivo and in vitro, suggesting that Aurora kinases could be a novel therapeutic target. In this review, we'll first briefly present the structure, localization and physiological functions of Aurora kinases in mitosis, then describe the oncogenic role of Aurora kinases in tumorigenesis, we shall finally discuss the outcomes of AKIs combination with conventional therapy.
format Online
Article
Text
id pubmed-5410356
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-54103562017-05-04 Aurora kinases: novel therapy targets in cancers Tang, Anqun Gao, Keyu Chu, Laili Zhang, Rui Yang, Jing Zheng, Junnian Oncotarget Review Aurora kinases, a family of serine/threonine kinases, consisting of Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are essential kinases for cell division via regulating mitosis especially the process of chromosomal segregation. Besides regulating mitosis, Aurora kinases have been implicated in regulating meiosis. The deletion of Aurora kinases could lead to failure of cell division and impair the embryonic development. Overexpression or gene amplification of Aurora kinases has been clarified in a number of cancers. And a growing number of studies have demonstrated that inhibition of Aurora kinases could potentiate the effect of chemotherapies. For the past decades, a series of Aurora kinases inhibitors (AKIs) developed effectively repress the progression and growth of many cancers both in vivo and in vitro, suggesting that Aurora kinases could be a novel therapeutic target. In this review, we'll first briefly present the structure, localization and physiological functions of Aurora kinases in mitosis, then describe the oncogenic role of Aurora kinases in tumorigenesis, we shall finally discuss the outcomes of AKIs combination with conventional therapy. Impact Journals LLC 2017-01-29 /pmc/articles/PMC5410356/ /pubmed/28147341 http://dx.doi.org/10.18632/oncotarget.14893 Text en Copyright: © 2017 Tang et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Review
Tang, Anqun
Gao, Keyu
Chu, Laili
Zhang, Rui
Yang, Jing
Zheng, Junnian
Aurora kinases: novel therapy targets in cancers
title Aurora kinases: novel therapy targets in cancers
title_full Aurora kinases: novel therapy targets in cancers
title_fullStr Aurora kinases: novel therapy targets in cancers
title_full_unstemmed Aurora kinases: novel therapy targets in cancers
title_short Aurora kinases: novel therapy targets in cancers
title_sort aurora kinases: novel therapy targets in cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410356/
https://www.ncbi.nlm.nih.gov/pubmed/28147341
http://dx.doi.org/10.18632/oncotarget.14893
work_keys_str_mv AT tanganqun aurorakinasesnoveltherapytargetsincancers
AT gaokeyu aurorakinasesnoveltherapytargetsincancers
AT chulaili aurorakinasesnoveltherapytargetsincancers
AT zhangrui aurorakinasesnoveltherapytargetsincancers
AT yangjing aurorakinasesnoveltherapytargetsincancers
AT zhengjunnian aurorakinasesnoveltherapytargetsincancers